Makers Laboratories (MAKERSL) Stock Overview

An integrated pharmaceutical company, manufactures and markets formulations in India. More details

MAKERSL fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 43.4% below our estimate of its fair value

Risk Analysis

Shares are highly illiquid

Profit margins (2.3%) are lower than last year (7.1%)

Does not have a meaningful market cap (₹1B)

MAKERSL Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW463,021 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

463,021 investors already sharing narratives

View all narratives

Makers Laboratories Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Makers Laboratories
Historical stock prices
Current Share Price	₹186.88
52 Week High	₹183.99
52 Week Low	₹150.00
Beta	0.16
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	16.92%

Recent updates

Shareholder Returns

	MAKERSL	IN Pharmaceuticals	IN Market
7D	n/a	-0.7%	-0.5%
1Y	n/a	15.2%	1.7%

Return vs Industry: Insufficient data to determine how MAKERSL performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how MAKERSL performed against the Indian Market.

Price Volatility

Is MAKERSL's price volatile compared to industry and market?
MAKERSL volatility
MAKERSL Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.1%
Market Average Movement	5.9%
10% most volatile stocks in IN Market	9.0%
10% least volatile stocks in IN Market	3.6%

Stable Share Price: MAKERSL's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine MAKERSL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1984	114	n/a	www.makerslabs.com

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid.

Makers Laboratories Limited Fundamentals Summary

How do Makers Laboratories's earnings and revenue compare to its market cap?
MAKERSL fundamental statistics
Market cap	₹1.03b
Earnings (TTM)	₹34.19m
Revenue (TTM)	₹1.49b

32.1x

P/E Ratio

0.7x

P/S Ratio

Is MAKERSL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MAKERSL income statement (TTM)
Revenue	₹1.49b
Cost of Revenue	₹697.02m
Gross Profit	₹789.42m
Other Expenses	₹755.23m
Earnings	₹34.19m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	5.79
Gross Margin	53.11%
Net Profit Margin	2.30%
Debt/Equity Ratio	5.0%

How did MAKERSL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/21 14:45
End of Day Share Price	2026/08/21 00:00
Earnings	2026/06/30
Annual Earnings	2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Makers Laboratories Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Anil Burra	FirstCall Research

Makers Laboratories LimitedNSEI:MAKERSL Stock Report